Sustained Efficacy and Safety of Relugolix Combination Therapy in Women with Endometriosis-Associated Pain: Spirit 52-Week Data

Sawsan As‐Sanie, Linda C. Giudice, Maurício Simões Abrão, Katarzyna Wilk, Claudia Mehedințu, Claudia Becker, Juan Camilo Arjona Ferreira, Rachel B. Wagman, F. Wang, Qurratul Ann Warsi, Neil Johnson
In: Journal of Minimally Invasive Gynecology · 2021 · vol. 28(11) , pp. S10–S11 · doi:10.1016/j.jmig.2021.09.031 · W3205665664
article OA: closed CC0 ⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study evaluated the sustained efficacy and safety of relugolix combination therapy for endometriosis-associated pain over 52 weeks.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK